News | Cardio-oncology

March 1, 2018 – Patients who were treated for breast cancer or lymphoma are more than three times at risk for developing ...

Home March 01, 2018
Home
News | Analytics Software

February 28, 2018 — Lumedx Corp. will show off the latest in advanced analytics and software solutions at the upcoming ...

Home February 28, 2018
Home
News | Cardiovascular Business

The American College of Cardiology’s Cardiovascular Summit will begin on Thursday, Feb. 22, 2018, bringing together leading experts from the entire cardiovascular care team to discuss and present best practices on operational excellence, cost efficiency, leadership training and workforce wellness during this time of changing healthcare delivery.

Home February 28, 2018
Home
A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.
Feature | Magnetic Resonance Imaging (MRI) | Dave Fornell

One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) used ...

Home February 28, 2018
Home
News | Magnetic Resonance Imaging (MRI)

A new study published in the Journal of the American College of Cardiology confirms non-invasive cardiac magnetic resonance (CMR) provides a highly accurate means of assessing mitral regurgitation in patients with valvular heart disease. Seth Uretsky, M.D., medical director of cardiovascular imaging and associate director of the Cardiovascular Fellowship Program at Atlantic Health System, served as the study’s lead author.

Home February 27, 2018
Home
News | Cath Lab

The American College of Cardiology (ACC) and the Saudi Arabian Cardiac Interventional Society have partnered to implement the NCDR CathPCI Registry in hospitals across Saudi Arabia. The CathPCI Registry assesses the characteristics, treatments and outcomes of heart disease patients who receive diagnostic catheterization as well as percutaneous coronary intervention procedures.

Home February 27, 2018
Home
News | Cybersecurity

Medical devices, including cardiovascular implantable electronic devices, could be at risk for hacking. In a paper published online in the Journal of the American College of Cardiology, the American College of Cardiology’s Electrophysiology Council examines the potential risk to patients and outlines how to improve cybersecurity in these devices.

Home February 27, 2018
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

The U.S. Food and Drug Administration (FDA) announced that Medtronic is recalling certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds) due to a defect in the manufacturing process. The FDA said this defect causes an out-of-specification gas mixture inside the device and may prevent the device from delivering the electrical shock needed to pace a patient’s heartbeat or revive a patient in cardiac arrest.

Home February 26, 2018
Home
Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.
Feature | Radiopharmaceuticals and Tracers | Dave Fornell

February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took ...

Home February 26, 2018
Home
News | Cardiovascular Ultrasound

February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are joining ...

Home February 26, 2018
Home
Technology | Stents Drug Eluting

February 26, 2018 – Designed specifically for small vessels, Medtronic plc announced U.S. Food and Drug Administration ...

Home February 26, 2018
Home
News | Heart Valve Technology

February 23, 2018 — Boston Scientific announced In November 2017 a delay to timelines for commercialization of the Lotus ...

Home February 23, 2018
Home
News | Cath Lab

February 23, 2018 — CorFlow Therapeutics AG announced that the company will present new insights into the coronary ...

Home February 23, 2018
Home
News | Heart Valve Technology

NaviGate Cardiac Structures Inc. (NCSI)announced that on Feb. 2, 2018, its catheter-guided Gate valved-stent bioprosthesis became the first Canadian orthotopic valve replacement to treat severe tricuspid regurgitation. The procedure was performed at the Quebec Heart and Lung Institute, Laval University (Quebec City, Canada) by the Institute’s Cardiac Team, led by Josep Rodés-Cabau, M.D., interventional cardiologist, an internationally known expert in tricuspid disease therapy; and François Dagenais, M.D., chief of cardiac surgery at the institute. They performed the Health Canada-sanctioned Expanded Access (Compassionate Use) procedure in the patient who presented with severe symptomatic tricuspid regurgitation.

Home February 22, 2018
Home
Videos

This video details the first use of a new protocol at The Ohio State University’s Wexner Medical Center to start sudden ...

Home February 22, 2018
Home
Subscribe Now